HOME >> MEDICINE >> NEWS
Area of Research Outlined For Promising New Cancer Drugs

The effects of angiostatin and endostatin on mechanisms regulating angiongenesis in other processes besides tumor growth is one area of research that requires additional study, according to noted University of Notre Dame blood chemist Francis J. Castellino.

Basic research conducted in Castellino's laboratory contributed to the identification of angiostatin, one of the promising new cancer drugs being heralded nationally this week. Angiostatin and endostatin are being given top priority by the National Cancer Institute and will be rushed to clinical trial in humans.

Castellino is very excited about the drugs' possibilities but cautions that more studies involving the basic science of these drugs are needed. Research now under way in Castellino's laboratories will attempt to address some of these issues.

Castellino, whose laboratory is without question one of the top handful studying blood clotting mechanisms, is Kleiderer-Pezold professor of biochemistry, dean of Notre Dame's College of Science, and director of the Center for Transgene Research and the Walther Cancer Center, which are also at the University. It was his antibody to plasminogen, a precurser of the clot-dissolving enzyme plasmin -- as well as a number of basic studies on plasminogen fragments -- that helped confirm angiostatin is a fragment of this protein. (Endostatin is derived from a different, unrelated protein, collagen XVIII.)

Angiostatin and endostatin were discovered in the laboratory of Dr. Judah Folkman, a cancer researcher at Children's Hospital in Boston. The drugs function by cutting off the blood supply to tumors, making even extremely large tumors disappear. In mice, the drugs appear to stop malignant tumor growth and spreading, but they have not yet been tested in humans, and the medical community remains cautious.

Both angiostatin and endostatin evidently in
'"/>

Contact: Francis J. Castellino
Francis.J.Castellino.1@nd.edu
(219) 631-6456
University of Notre Dame
8-May-1998


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 04, 2020 , ... Today, Power to Decide’s ... Programs (AMCHP) with the 2020 Innovation Station Best Practice Award. The One Key Question ... what circumstances to get pregnant and have a child. One Key Question is used ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... announced enrollment of the first patients with first-line advanced pancreatic cancer in a ... 1/2 1801 trial of 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small ...
(Date:7/31/2020)... ... July 31, 2020 , ... National ... the following statement today regarding the nation’s ongoing preparations for the eventual deployment ... nation with an efficient, effective and essential component of vaccine deployment. They will ...
(Date:7/22/2020)... ... , ... Ocean Tomo Transactions, LLC will auction a patent ... Brock University for jurisdictions throughout North America, Europe and Asia. Ocean Tomo ... manufacturing processes of novel opioid related compositions for pain management as well as ...
(Date:7/18/2020)... ... July 17, 2020 , ... HMI Performance Incentives’ campaign, Spread ... was a charitable push put together to help spread positivity in the wake ... pandemic, HMI asked individuals in its audience to share stories, answering questions such ...
Breaking Medicine News(10 mins):
(Date:7/18/2020)... ... 17, 2020 , ... The Women’s Fund Miami-Dade has launched ... who are experiencing abuse know that services are available 24/7, and to encourage ... County’s Coordinated Victim’s Assistance Center (CVAC) helpline. Although there hasn’t been an overwhelming ...
(Date:7/10/2020)... ... July 10, 2020 , ... A prominent ... in partnership with Dr. Shashi Kusuma, a plastic surgeon, is introducing Cliovana to ... Health division. This service/treatment is a first-of-its-kind specifically focused on female arousal and ...
(Date:7/10/2020)... (PRWEB) , ... July 10, 2020 , ... ... developed new guidance for HIPAA Compliance for Business Associates. Business associates create, receive, ... entity clients. As such, business associates are required to be HIPAA compliant, ensuring ...
Breaking Medicine Technology:
Cached News: